Erratum: Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system (International Journal of Radiation Oncology Biology Physics (2011) 79:5 (1487-95) DOI: 10.1016/j.ijrobp.2009.12.061);Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1487-1495

  Levin, Victor A ^a   Bidaut, Luc ^a   Hou, Ping ^a   Kumar, Ashok J ^a   Wefel, Jeffrey S ^a   Bekele, B Nebiyou ^a   Prabhu, Sujit ^a   Loghin, Monica ^a   Gilbert, Mark R ^a   Jackson, Edward F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Brain edema; Endothelial transfer constant; Magnetic resonance imaging; neurotoxicity; Volumetric magnetic resonance imaging changes

Indexed keywords

DISEASES; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAGNETISM; NEUROPHYSIOLOGY; RADIATION; RADIOTHERAPY; RESONANCE;

BRAIN EDEMA; CENTRAL NERVOUS SYSTEMS; FLUID ATTENUATED INVERSION RECOVERIES; HEAD-AND-NECK CANCER; METHODS AND MATERIALS; NEUROTOXICITY; TRANSFER CONSTANT; VOLUMETRIC MAGNETIC RESONANCE IMAGING CHANGES;

PATIENT REHABILITATION;

BEVACIZUMAB; DEXAMETHASONE; ENOXAPARIN; GADOLINIUM; PLACEBO; PREDNISONE; SODIUM CHLORIDE; VASCULOTROPIN INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN BIOPSY; BRAIN NECROSIS; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEEP VEIN THROMBOSIS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLIOMA; HEAD AND NECK CARCINOMA; HEMIPLEGIA; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SAGITTAL SINUS THROMBOSIS; SIDE EFFECT; SYMPTOM; TREATMENT RESPONSE; VISUAL FIELD;

EID: 79952698481     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.04.026     Document Type: Erratum

References (28)

1. Cheung M-C, Chan AS, Law SC, et al. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer 2003;97:2019-2026. (Pubitemid 36397281)
2. Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurology 2003;9:180-188. (Pubitemid 36944725)
3. Crossen JR, Garwood D, Glatstein E, et al. Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-642. (Pubitemid 24079908)
4. Leibel SA, Sheline GE. Tolerance of the brain and spinal cord to conventional irradiation. In: Gutin PH, Leibel SA, Sheline GE, editors. Radiation injury to the nervous system. New York: Raven Press; 1991. p. 211-239.
5. Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In: DeVita VTJ, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology. 6th ed. Philadelphia: Lippincott-Raven; 2001. p. 2100-2160.
6. Glantz MJ, Burger PC, Friedman AH, et al. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 1994;44:2020-2027. (Pubitemid 24349499)
7. Kim JH, Chung YG, Kim CY, et al. Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy. J Korean Med Sci 2004;19:879-886. (Pubitemid 40104884)
8. Li Y-Q, Ballinger JR, Nordal RA, et al. Hypoxia in radiation-induced blood-spinal cord barrier breakdown. Cancer Res 2001;61:3348-3354. (Pubitemid 32695024)
9. Tsao MN, Li YQ, Lu G, et al. Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown. J Neuropathol Exp Neurol 1999;58:1051-1060. (Pubitemid 29468266)
10. Kim JH, Chung YG, Kim CY, et al. Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy. J Korean Med Sci 2004;19:879-886. (Pubitemid 40104884)
11. Gridley DS, Loredo LN, Slater JD, et al. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev 1998;22:20-29. (Pubitemid 28073337)
12. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exper Med 1991;174:1275-1278.
13. Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
14. Senger DR, Perruzzi CA, Feder J, et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46:5629-5632. (Pubitemid 17177959)
15. Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast Rev 1993;12:303-324. (Pubitemid 23293287)
16. Presta LG, Chen H, O'Connor SJ, et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997;57:4593-4599. (Pubitemid 27441066)
17. Gonzalez J, Kumar AJ, Conrad CA, et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007;67:323-326. (Pubitemid 46108339)
18. Torcuator R, Zuniga R, Mohan YS, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009;94:63-68.
19. Meyer CR, Johnson TD, McLennan G, et al. Evaluation of lung MDCT nodule annotation across radiologists and methods. Acad Radiol 2006;13:1254-1265. (Pubitemid 44345260)
20. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101. (Pubitemid 28365643)
21. Reitan RM. Trail Making Test manual for administration and scoring. Tucson: Reitan Neuropsychology Laboratory; 1992.
22. Benedict RHB, Schretlen D, Groninger L, et al. Hopkins verbal learning test - Revised: Normative data and analysis of interform and test-retest reliability. Clin Psychologist 1998;12:43-55. (Pubitemid 28168220)
23. Benton AL, Hamsher K. Multilingual aphasia examination. Iowa City: AJA Associates; 1983.
24. Heaton RK, Miller SW, Taylor MJ, et al. Revised comprehensive norms for an expanded Halstead - Reitan battery. Odessa, FL: Psychological Assessment Resources; 2004.
25. Leeds NE, Kumar AJ, Jackson EF. Diagnostic imaging. In: Levin VA, editor. Cancer in the nervous system. 2nd ed. New York: Oxford University Press; 2002. p. 3-59.
26. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000;217:377-384.
27. Sackett D. Evidence-based medicine. Lancet 1995;346:1171.
28. Welsh-Bohmer KA, Ogrock PK. Clinical differentiation of memory disorders in neurodegenerative disease. In: Troster AI, editor. Memory in neurodegenerative disease: Biological, cognitive, and clinical perspectives. Cambridge, UK: Cambridge University Press; 1998. p. 290-314.